Rotavirus vaccine trial in Jamaica

Worldwide, rotaviruses have been a significant cause of dehydrating gastroenteritis. This contributed to increased infant morbidity and mortality in Jamaica. We enrolled 1804 Jamaican infants in the international randomized, placebo-controlled, pentavalent (G1, G2, G3, G4 and P1) rotavirus vaccine t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:West Indian medical journal 2012-07, Vol.61 (4), p.405-407
Hauptverfasser: Christie, C D C, Duncan, N D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 407
container_issue 4
container_start_page 405
container_title West Indian medical journal
container_volume 61
creator Christie, C D C
Duncan, N D
description Worldwide, rotaviruses have been a significant cause of dehydrating gastroenteritis. This contributed to increased infant morbidity and mortality in Jamaica. We enrolled 1804 Jamaican infants in the international randomized, placebo-controlled, pentavalent (G1, G2, G3, G4 and P1) rotavirus vaccine trial. This pentavalent vaccine was found to significantly reduce rotavirus gastroenteritis attributable emergency room visits and hospitalizations, without increasing the rates of intussusception, or other serious adverse events in Jamaican infants. It is recommended that the rotavirus vaccine be included in Jamaica's National Immunization Programme in accordance with recommendations from the World Health Organization.
doi_str_mv 10.7727/wimj.2012.219
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1240211505</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1240211505</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-6ad0f9b74d98921fec1dd346eaf0a80aa498e2f1f2f1c3549d8e9060c8ee3b6f3</originalsourceid><addsrcrecordid>eNo9kEtLw0AUhWeh2FpdupXgyk3inUcnmaUUnxQE0fVwO7kDU5KmziQV_70prS4OZ_NxOHyMXXEoylKUd9-hXRcCuCgENydsCqBkLrlSE3ae0hpAS67hjE2EFApUqafs5r3rcRfikLIdOhc2lPUxYJOFTfaKLQaHF-zUY5Po8tgz9vn48LF4zpdvTy-L-2XupNB9rrEGb1alqk1lBPfkeF1LpQk9YAWIylQkPPdjnJwrU1dkQIOriORKezljt4fdbey-Bkq9bUNy1DS4oW5Ilo-fBedzmI9ofkBd7FKK5O02hhbjj-Vg9yrsXoXdq7CjipG_Pk4Pq5bqf_rPg_wFkrhbLg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1240211505</pqid></control><display><type>article</type><title>Rotavirus vaccine trial in Jamaica</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Christie, C D C ; Duncan, N D</creator><creatorcontrib>Christie, C D C ; Duncan, N D</creatorcontrib><description>Worldwide, rotaviruses have been a significant cause of dehydrating gastroenteritis. This contributed to increased infant morbidity and mortality in Jamaica. We enrolled 1804 Jamaican infants in the international randomized, placebo-controlled, pentavalent (G1, G2, G3, G4 and P1) rotavirus vaccine trial. This pentavalent vaccine was found to significantly reduce rotavirus gastroenteritis attributable emergency room visits and hospitalizations, without increasing the rates of intussusception, or other serious adverse events in Jamaican infants. It is recommended that the rotavirus vaccine be included in Jamaica's National Immunization Programme in accordance with recommendations from the World Health Organization.</description><identifier>ISSN: 0043-3144</identifier><identifier>DOI: 10.7727/wimj.2012.219</identifier><identifier>PMID: 23240476</identifier><language>eng</language><publisher>Jamaica</publisher><subject>Disease Outbreaks ; Environmental Exposure ; Gastroenteritis - virology ; Humans ; Jamaica ; Rotavirus Infections - prevention &amp; control ; Rotavirus Vaccines - therapeutic use ; Vaccines, Attenuated - therapeutic use</subject><ispartof>West Indian medical journal, 2012-07, Vol.61 (4), p.405-407</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c326t-6ad0f9b74d98921fec1dd346eaf0a80aa498e2f1f2f1c3549d8e9060c8ee3b6f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23240476$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Christie, C D C</creatorcontrib><creatorcontrib>Duncan, N D</creatorcontrib><title>Rotavirus vaccine trial in Jamaica</title><title>West Indian medical journal</title><addtitle>West Indian Med J</addtitle><description>Worldwide, rotaviruses have been a significant cause of dehydrating gastroenteritis. This contributed to increased infant morbidity and mortality in Jamaica. We enrolled 1804 Jamaican infants in the international randomized, placebo-controlled, pentavalent (G1, G2, G3, G4 and P1) rotavirus vaccine trial. This pentavalent vaccine was found to significantly reduce rotavirus gastroenteritis attributable emergency room visits and hospitalizations, without increasing the rates of intussusception, or other serious adverse events in Jamaican infants. It is recommended that the rotavirus vaccine be included in Jamaica's National Immunization Programme in accordance with recommendations from the World Health Organization.</description><subject>Disease Outbreaks</subject><subject>Environmental Exposure</subject><subject>Gastroenteritis - virology</subject><subject>Humans</subject><subject>Jamaica</subject><subject>Rotavirus Infections - prevention &amp; control</subject><subject>Rotavirus Vaccines - therapeutic use</subject><subject>Vaccines, Attenuated - therapeutic use</subject><issn>0043-3144</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtLw0AUhWeh2FpdupXgyk3inUcnmaUUnxQE0fVwO7kDU5KmziQV_70prS4OZ_NxOHyMXXEoylKUd9-hXRcCuCgENydsCqBkLrlSE3ae0hpAS67hjE2EFApUqafs5r3rcRfikLIdOhc2lPUxYJOFTfaKLQaHF-zUY5Po8tgz9vn48LF4zpdvTy-L-2XupNB9rrEGb1alqk1lBPfkeF1LpQk9YAWIylQkPPdjnJwrU1dkQIOriORKezljt4fdbey-Bkq9bUNy1DS4oW5Ilo-fBedzmI9ofkBd7FKK5O02hhbjj-Vg9yrsXoXdq7CjipG_Pk4Pq5bqf_rPg_wFkrhbLg</recordid><startdate>20120701</startdate><enddate>20120701</enddate><creator>Christie, C D C</creator><creator>Duncan, N D</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120701</creationdate><title>Rotavirus vaccine trial in Jamaica</title><author>Christie, C D C ; Duncan, N D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-6ad0f9b74d98921fec1dd346eaf0a80aa498e2f1f2f1c3549d8e9060c8ee3b6f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Disease Outbreaks</topic><topic>Environmental Exposure</topic><topic>Gastroenteritis - virology</topic><topic>Humans</topic><topic>Jamaica</topic><topic>Rotavirus Infections - prevention &amp; control</topic><topic>Rotavirus Vaccines - therapeutic use</topic><topic>Vaccines, Attenuated - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Christie, C D C</creatorcontrib><creatorcontrib>Duncan, N D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>West Indian medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Christie, C D C</au><au>Duncan, N D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rotavirus vaccine trial in Jamaica</atitle><jtitle>West Indian medical journal</jtitle><addtitle>West Indian Med J</addtitle><date>2012-07-01</date><risdate>2012</risdate><volume>61</volume><issue>4</issue><spage>405</spage><epage>407</epage><pages>405-407</pages><issn>0043-3144</issn><abstract>Worldwide, rotaviruses have been a significant cause of dehydrating gastroenteritis. This contributed to increased infant morbidity and mortality in Jamaica. We enrolled 1804 Jamaican infants in the international randomized, placebo-controlled, pentavalent (G1, G2, G3, G4 and P1) rotavirus vaccine trial. This pentavalent vaccine was found to significantly reduce rotavirus gastroenteritis attributable emergency room visits and hospitalizations, without increasing the rates of intussusception, or other serious adverse events in Jamaican infants. It is recommended that the rotavirus vaccine be included in Jamaica's National Immunization Programme in accordance with recommendations from the World Health Organization.</abstract><cop>Jamaica</cop><pmid>23240476</pmid><doi>10.7727/wimj.2012.219</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0043-3144
ispartof West Indian medical journal, 2012-07, Vol.61 (4), p.405-407
issn 0043-3144
language eng
recordid cdi_proquest_miscellaneous_1240211505
source MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects Disease Outbreaks
Environmental Exposure
Gastroenteritis - virology
Humans
Jamaica
Rotavirus Infections - prevention & control
Rotavirus Vaccines - therapeutic use
Vaccines, Attenuated - therapeutic use
title Rotavirus vaccine trial in Jamaica
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T21%3A49%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rotavirus%20vaccine%20trial%20in%20Jamaica&rft.jtitle=West%20Indian%20medical%20journal&rft.au=Christie,%20C%20D%20C&rft.date=2012-07-01&rft.volume=61&rft.issue=4&rft.spage=405&rft.epage=407&rft.pages=405-407&rft.issn=0043-3144&rft_id=info:doi/10.7727/wimj.2012.219&rft_dat=%3Cproquest_cross%3E1240211505%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1240211505&rft_id=info:pmid/23240476&rfr_iscdi=true